HIV診断の世界市場、2030年までの予測：製品別、検査タイプ別、エンドユーザー別、地域別の世界分析

Stratistics MRCによると、世界のHIV診断市場は2023年に10億5,960万米ドルを占め、予測期間中のCAGRは7.4%で成長し、2030年には17億5,790万米ドルに達すると予測されています。

HIV診断とは、個人の体内のヒト免疫不全ウイルス（HIV）の存在を特定するプロセスを指します。これは通常、血液、唾液、その他の体液中のHIV抗体やウイルス遺伝物質など、ウイルスの特異的マーカーを検出する様々な検査室検査によって達成されます。正確な診断は、個人のHIVステータスを決定するために不可欠であり、治療を開始し、病気を管理し、その蔓延を防ぐために極めて重要です。

世界保健機関（WHO）によると、2016年には世界で約3,600万人がHIVと診断され、そのうち210万人が新規HIV感染者であったと報告されています。

HIV診断に対する需要の高まり

後天性免疫不全症候群の原因となるヒト免疫不全ウイルス（HIV）は、HIV診断によって検出される可能性があるため、これらのサービスに対するニーズが高まっています。また、血清、唾液、尿を検査することでHIVの診断が可能であり、抗体、抗原、RNAの検出を補助することから、HIV診断プロセスの売上が増加すると予測されます。さらに、人々がHIV、検査の機密性、適切なカウンセリングに関する知識を深めるにつれて、HIV診断薬に対する需要も高まっています。したがって、HIV診断薬市場はこれらの要因によって急速に拡大すると予想されます。

高額な費用

HIV診断検査は、特に高度で精密な検査の場合、状況や検査の種類によっては高額になる可能性があります。さらに、特に資源の乏しい環境や、適切なヘルスケアにアクセスできない人々にとっては、検査に伴う費用が障害となる可能性があります。その結果、市場の拡大がかなり阻害されることになります。

政府の制度とプログラム

世界各国政府は、予防、検査、治療を優先する包括的な計画を実施することで、HIV/AIDSの流行に対する取り組みを強化しています。さらに、これらのプログラムは、特にハイリスク集団の間で定期的なHIV検査の普及率を高め、最先端の診断ツールへのアクセスを開放することを目指しています。さらに、各国政府は、HIV診断機器の入手しやすさとコストを向上させるために、製薬企業、非政府組織（NGO）、ヘルスケア組織間の協力も奨励しており、世界のHIVの負担を軽減するために協力することで、市場の拡大を促しています。

知識不足と偽陽性結果

多くの人々、特にリスクの高い地域に住む人々は、早期診断の価値を知らず、HIV検査に関する知識も限られています。検査率の低さや診断の遅れは、教育や啓発活動の不足が原因である可能性があり、適切な管理や予防対策の妨げとなっています。さらに、偽陽性は過剰な心配とストレスをもたらし、偽陰性は診断を遅らせ、ウイルス感染のリスクを高める。このように、これらの要因が市場規模を徐々に阻害しています。

COVID-19の影響

コロナウイルス（COVID-19）の大流行による世界の封鎖は、あらゆる業界の企業の財務の健全性に影響を及ぼしています。さらに、政府による封鎖、移動制限、その他のCOVID-19安全対策の結果、世界のサプライチェーンと製造業務が影響を受けています。そのため、流行期にはHIV診断検査のニーズは減少すると予想されます。

予測期間中、機器セグメントが最大となる見込み

専門的な医療ツールや技術を活用することで、HIV感染を検出・追跡できるため、機器セグメントが最大のシェアを占めると推定されます。さらに、これらの技術により、医療従事者は患者サンプル中のHIV抗体やウイルス遺伝物質を正確に特定することができます。これらの装置の例としては、PCR装置、ELISA分析装置、迅速検査リーダーなどの診断ツールがあります。さらに、これらの最先端ツールは、早期発見、疾患モニタリング、研究に不可欠であり、迅速かつ正確なHIV検査を可能にします。また、医療専門家、検査室、クリニックが効率的な診断ソリューションを提供できるよう支援し、HIVの蔓延を抑制するための継続的な取り組みを促進するのに役立っています。したがって、これらの要因が市場規模を大きく押し上げています。

CD4検査分野は予測期間中に最も高いCAGRが見込まれる

CD4検査分野は、予測期間中にCAGRが最も高くなると予測されています。CD4検査は、病気の経過を示し、患者の免疫システムの健康状態を測定するため、HIV/AIDSのコントロールに不可欠です。さらに、これらの検査は医療専門家が治療方針を決定し、抗レトロウイルス薬の有効性を評価するのに役立ちます。さらに、患者のケアを指示し、病気を管理するためには、正確で迅速なCD4検査が不可欠です。したがって、HIV診断市場で重要な役割を果たすことで、HIV感染者の治療成績の向上と生活の質全体の向上に貢献します。

最大のシェアを占める地域

アジア太平洋は、インド、中国、日本のような国々で啓発キャンペーンが増加し、HIV診断件数が増加したため、予測期間中に最大の市場シェアを占めました。さらに、社会経済的・人口統計的要因の変化により、これらの国々ではHIVの診断件数が増加しています。さらに、ヘルスケア機関や啓発プログラムへの投資が増加していることも、アジア太平洋の市場拡大を後押ししています。

CAGRが最も高い地域

欧州は、早期発見の促進、国家的検査政策の策定、HIV検査サービスへのアクセス増加などの著しい進展により、予測期間中に最も高いCAGRを記録すると予想されます。さらに、この地域はHIVに関連する偏見や差別を軽減することを目指しており、これによって人々が検査を受けることを奨励しています。さらに、政府、ヘルスケア機関、NGOが協力することで、検査率の向上と診断の迅速化が実現し、欧州地域の市場拡大を大きく後押ししています。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます。

• 企業プロファイル
  • 追加市場企業の包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査源
  • 1次調査源
  • 2次調査源
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 製品分析
• エンドユーザー分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界のHIV診断市場：製品別

• ソフトウェアとサービス
• 機器
• 消耗品
  • アッセイおよびキット・試薬
  • その他の消耗品

第6章 世界のHIV診断市場：検査タイプ別

• 抗体検査
  • HIV-1スクリーニング検査
    • エリサ
    • ホームアクセス乾いた血液スポット
    • 迅速なテスト
  • HIV-1抗体確認検査
    • ウェスタンブロット検査
    • ラインイムノアッセイ
    • 間接免疫蛍光アッセイ（IFA）
    • ラジオ免疫沈降アッセイ
  • HIV-2およびグループ O診断検査
• ウイルス量検査
• 乳児の早期診断用検査
• CD4テスト
• ウイルス識別用検査

第7章 世界のHIV診断市場：エンドユーザー別

• 病院・クリニック
• 診断研究所
• 在宅医療設定
• その他のエンドユーザー

第8章 世界のHIV診断市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他の欧州
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他のアジア太平洋
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他の南米
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他の中東・アフリカ

第9章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第10章 企業プロファイル

• Abbott Laboratories
• Roche Diagnostics
• Merck KGaA
• Siemens Healthineers
• Thermo-Fisher Scientific Inc.
• Beckman Coulter, Inc.
• Hologic Inc.
• Becton, Dickinson & Company
• Bio-Rad Laboratories
• Alere Inc.
• OraSure Technologies, Inc.
• Zyomyx Incorporation
• Chembio Diagnostic Systems, Inc.
• Janssen Pharmaceutica NV
• Bristol-Myers Squibb

List of Tables

• Table 1 Global HIV Diagnosis Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
• Table 3 Global HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
• Table 4 Global HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
• Table 5 Global HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
• Table 6 Global HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
• Table 7 Global HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
• Table 8 Global HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
• Table 9 Global HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
• Table 10 Global HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
• Table 11 Global HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
• Table 12 Global HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
• Table 13 Global HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
• Table 14 Global HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
• Table 15 Global HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
• Table 16 Global HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
• Table 17 Global HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
• Table 18 Global HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 19 Global HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
• Table 20 Global HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
• Table 21 Global HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 22 North America HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
• Table 23 North America HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
• Table 24 North America HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
• Table 25 North America HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
• Table 26 North America HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
• Table 27 North America HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
• Table 28 North America HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
• Table 29 North America HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
• Table 30 North America HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
• Table 31 North America HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
• Table 32 North America HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
• Table 33 North America HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
• Table 34 North America HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
• Table 35 North America HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
• Table 36 North America HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
• Table 37 North America HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
• Table 38 North America HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
• Table 39 North America HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 40 North America HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
• Table 41 North America HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
• Table 42 North America HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 43 Europe HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
• Table 44 Europe HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
• Table 45 Europe HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
• Table 46 Europe HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
• Table 47 Europe HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
• Table 48 Europe HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
• Table 49 Europe HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
• Table 50 Europe HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
• Table 51 Europe HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
• Table 52 Europe HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
• Table 53 Europe HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
• Table 54 Europe HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
• Table 55 Europe HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
• Table 56 Europe HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
• Table 57 Europe HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
• Table 58 Europe HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
• Table 59 Europe HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
• Table 60 Europe HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 61 Europe HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
• Table 62 Europe HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
• Table 63 Europe HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 64 Asia Pacific HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
• Table 65 Asia Pacific HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
• Table 66 Asia Pacific HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
• Table 67 Asia Pacific HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
• Table 68 Asia Pacific HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
• Table 69 Asia Pacific HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
• Table 70 Asia Pacific HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
• Table 71 Asia Pacific HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
• Table 72 Asia Pacific HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
• Table 73 Asia Pacific HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
• Table 74 Asia Pacific HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
• Table 75 Asia Pacific HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
• Table 76 Asia Pacific HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
• Table 77 Asia Pacific HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
• Table 78 Asia Pacific HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
• Table 79 Asia Pacific HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
• Table 80 Asia Pacific HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
• Table 81 Asia Pacific HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 82 Asia Pacific HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
• Table 83 Asia Pacific HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
• Table 84 Asia Pacific HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 85 South America HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
• Table 86 South America HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
• Table 87 South America HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
• Table 88 South America HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
• Table 89 South America HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
• Table 90 South America HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
• Table 91 South America HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
• Table 92 South America HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
• Table 93 South America HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
• Table 94 South America HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
• Table 95 South America HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
• Table 96 South America HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
• Table 97 South America HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
• Table 98 South America HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
• Table 99 South America HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
• Table 100 South America HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
• Table 101 South America HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
• Table 102 South America HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 103 South America HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
• Table 104 South America HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
• Table 105 South America HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 106 Middle East & Africa HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
• Table 107 Middle East & Africa HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
• Table 108 Middle East & Africa HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
• Table 109 Middle East & Africa HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
• Table 110 Middle East & Africa HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
• Table 111 Middle East & Africa HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
• Table 112 Middle East & Africa HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
• Table 113 Middle East & Africa HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
• Table 114 Middle East & Africa HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
• Table 115 Middle East & Africa HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
• Table 116 Middle East & Africa HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
• Table 117 Middle East & Africa HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
• Table 118 Middle East & Africa HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
• Table 119 Middle East & Africa HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
• Table 120 Middle East & Africa HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
• Table 121 Middle East & Africa HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
• Table 122 Middle East & Africa HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
• Table 123 Middle East & Africa HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 124 Middle East & Africa HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
• Table 125 Middle East & Africa HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
• Table 126 Middle East & Africa HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)

According to Stratistics MRC, the Global HIV Diagnosis Market is accounted for $1059.6 million in 2023 and is expected to reach $1757.9 million by 2030 growing at a CAGR of 7.4% during the forecast period. HIV diagnosis refers to the process of identifying the presence of the human immunodeficiency virus (HIV) in an individual's body. It is typically accomplished through various laboratory tests that detect specific markers of the virus, such as HIV antibodies or viral genetic material in blood, saliva, or other bodily fluids. The accurate diagnosis is essential for determining an individual's HIV status, which is crucial for initiating treatment, managing the disease, and preventing its spread.

According to the World Health Organization (WHO), in 2016, around 36 million people were diagnosed with HIV globally, of which 2.1 million were reported to be cases of new HIV infections.

Market Dynamics:

Driver:

Rising demand for HIV diagnosis

Since the human immunodeficiency virus (HIV), which causes acquired immunodeficiency syndrome, may be detected by HIV diagnostics, by which there is an increasing need for these services. Moreover, testing serum, saliva, or urine samples allows for the diagnosis of HIV and as these methods assist in detecting antibodies, antigens, and RNA, it is projected that sales of HIV diagnostic processes will rise. Additionally, as people become more knowledgeable about HIV, the confidentiality of the test, and appropriate counselling, the demand for HIV diagnostics is also rising. Hence, the HIV diagnostics market is anticipated to expand quickly as a result of these factors.

Restraint:

High expenses

HIV diagnostic tests can be expensive, particularly for more sophisticated and precise testing procedures, depending on the context and type of test. Additionally, costs associated with testing can be an obstacle, especially in environments with few resources or for people without access to adequate healthcare. Consequently, this considerably disrupts the market's expansion.

Opportunity:

Government schemes and programs

Worldwide, governments are stepping up their efforts to tackle the HIV/AIDS pandemic by putting in place comprehensive plans that prioritize prevention, testing, and treatment. Additionally, these programs seek to increase the prevalence of routine HIV testing, particularly among high-risk populations, and to open up access to cutting-edge diagnostic tools. Furthermore, governments also encourage collaborations among pharmaceutical firms, non-governmental organizations (NGOs), and healthcare organizations to increase the accessibility and cost of HIV diagnostic equipment, which in turn drives market expansion as they cooperate to mitigate the burden of HIV worldwide

Threat:

Lack of knowledge and false-positive results

A lot of people, especially those who live in high-risk areas, can be unaware of the value of early diagnosis and have limited knowledge about HIV testing. Low testing rates and delayed diagnoses might be caused by a lack of education and awareness actions, hindering adequate management and prevention measures. Furthermore, false-positive results can result in too much worry and stress, while false-negative results can delay diagnosis and increase the risk of virus transmission. Thus, these factors gradually hamper the size of the market.

COVID-19 Impact

The global lockdown caused by the corona virus (COVID-19) pandemic has had an effect on the financial health of companies in all industries. Additionally, global supply chains and manufacturing operations have been affected as a result of government-enforced lockdowns, mobility restrictions, and other COVID-19 safety measures. Therefore, during the epidemic, the need for HIV diagnostic tests is anticipated to decline.

The instruments segment is expected to be the largest during the forecast period

The instruments segment is estimated to hold the largest share, due to utilizing specialized medical tools and technology, HIV infection is detected and tracked. Additionally, these technologies enable medical personnel to precisely identify HIV antibodies or viral genetic material in patient samples. Examples of these devices include diagnostic tools including PCR machines, ELISA analyzers, and quick test readers. Moreover, these cutting-edge tools are essential for early detection, disease monitoring, and research, enabling quick and accurate HIV testing. They also assist healthcare professionals, labs, and clinics in delivering efficient diagnostic solutions, which helps to further the continuing efforts to restrict the spread of HIV. Therefore, these factors significantly drive the market's size.

The CD4 Tests segment is expected to have the highest CAGR during the forecast period

The CD4 Tests segment is anticipated to have highest CAGR during the forecast period. CD4 tests are essential for controlling HIV/AIDS since they show the disease's course and measure the patient's immune system's health. Additionally, these tests assist medical professionals in deciding on a course of treatment and assessing the efficacy of antiretroviral medication. Moreover, for directing patient care and managing diseases, accurate and prompt CD4 testing is essential. Thus, it contributes to better treatment outcomes and overall quality of life for people with HIV by playing a vital role in the market for HIV diagnosis.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to increasing awareness-raising campaigns in nations like India, China, and Japan have increased the number of HIV diagnoses. Moreover, because of shifting socioeconomic and demographic factors, there are more HIV diagnoses in these nations. Additionally, rising healthcare institution and awareness program investments are driving market expansion in the Asia Pacific region.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period, owing to significant progress in boosting early detection, creating national testing policies, and increasing access to HIV testing services. Additionally, the area aims to reduce the stigma and discrimination related to HIV, which encourages people to be tested. Furthermore, governments, healthcare institutions, and NGOs working together have increased testing rates and accelerated diagnosis which thus significantly propels the market expansion in Europe region.

Key players in the market:

Some of the key players in the HIV Diagnosis Market include: Abbott Laboratories, Roche Diagnostics, Merck KGaA, Siemens Healthineers, Thermo-Fisher Scientific Inc., Beckman Coulter, Inc., Hologic Inc., Becton, Dickinson & Company , Bio-Rad Laboratories, Alere Inc., OraSure Technologies, Inc., Zyomyx Incorporation, Chembio Diagnostic Systems, Inc., Janssen Pharmaceutica NV and Bristol -Myers Squibb.

Key Developments:

In August 2023, Abbott Laboratories has collaborated with Redcliffe Labs to introduce Clinical Decision Support (CDS) also known as AlinIQ, powered by various proprietary technologies including Big Data Engines and Artificial Intelligence (AI). This development aims to revolutionise healthcare, offering solutions to enhance patient care and convenience.

In Jan 2022, Bristol-Myers Squibb and Century Therapeutics enter into a strategic collaboration to develop iPSC-derived Allogeneic Cell Therapies. The collaboration with Century Therapeutics is an important part of their investment strategy in next-generation cell therapies for hematologic and solid tumors.

Products Covered:

• Software & Services
• Instruments
• Consumables

Test Types Covered:

• Antibody Tests
• Viral Load Tests
• Tests for Early Infant Diagnosis
• CD4 Tests
• Tests for Viral Identification

End Users Covered:

• Hospitals & Clinics
• Diagnostic Laboratories
• Home Settings
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global HIV Diagnosis Market, By Product

• 5.1 Introduction
• 5.2 Software & Services
• 5.3 Instruments
• 5.4 Consumables
  • 5.4.1 Assays and Kits & Reagents
  • 5.4.2 Other Consumables

6 Global HIV Diagnosis Market, By Test Type

• 6.1 Introduction
• 6.2 Antibody Tests
  • 6.2.1 HIV-1 Screening Tests
    • 6.2.1.1 Elisa
    • 6.2.1.2 Home Access Dried Blood Spots
    • 6.2.1.3 Rapid Tests
  • 6.2.2 HIV-1 Antibody Confirmatory Tests
    • 6.2.2.1 Western Blot Tests
    • 6.2.2.2 Line Immunoassays
    • 6.2.2.3 Indirect Immunofluorescence Assays (IFA)
    • 6.2.2.4 Radio-Immunoprecipitation Assays
  • 6.2.3 HIV-2 & Group O Diagnostic Tests
• 6.3 Viral Load Tests
• 6.4 Tests for Early Infant Diagnosis
• 6.5 CD4 Tests
• 6.6 Tests for Viral Identification

7 Global HIV Diagnosis Market, By End User

• 7.1 Introduction
• 7.2 Hospitals & Clinics
• 7.3 Diagnostic Laboratories
• 7.4 Home Settings
• 7.5 Other End Users

8 Global HIV Diagnosis Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Abbott Laboratories
• 10.2 Roche Diagnostics
• 10.3 Merck KGaA
• 10.4 Siemens Healthineers
• 10.5 Thermo-Fisher Scientific Inc.
• 10.6 Beckman Coulter, Inc.
• 10.7 Hologic Inc.
• 10.8 Becton, Dickinson & Company
• 10.9 Bio-Rad Laboratories
• 10.10 Alere Inc.
• 10.11 OraSure Technologies, Inc.
• 10.12 Zyomyx Incorporation
• 10.13 Chembio Diagnostic Systems, Inc.
• 10.14 Janssen Pharmaceutica NV
• 10.15 Bristol -Myers Squibb